Icares Medicus Inc (6612) — Capital Reinvestment Ratio
Latest as of June 2025:
0.18x
Icares Medicus Inc (6612) has a Capital Reinvestment Ratio of 0.18x as of June 2025, meaning it reinvests 0% of its operating cash flow (NT$111.22 Million) in capital expenditures (NT$20.18 Million). See Icares Medicus Inc (6612) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.18x
Capex / Operating Cash Flow
Operating Cash Flow
NT$111.22 Million
TWD
Capital Expenditures
NT$20.18 Million
TWD
Data as of
Jun 2025
Most recent filing
Icares Medicus Inc Capital Reinvestment Ratio (2017–2022)
This chart tracks Icares Medicus Inc's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Icares Medicus Inc (2017–2022)
Year-by-year Capital Reinvestment Ratio for Icares Medicus Inc from 2017 to 2022. For live market cap and broader valuation context, see 6612 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.26x | NT$128.92 Million | NT$34.03 Million | ▲ +57.2% |
| 2021 | 0.17x | NT$38.57 Million | NT$6.48 Million | ▲ +7.0% |
| 2020 | 0.16x | NT$71.37 Million | NT$11.20 Million | ▼ -85.1% |
| 2019 | 1.05x | NT$88.78 Million | NT$93.41 Million | ▲ +995.0% |
| 2018 | 0.10x | NT$63.22 Million | NT$6.08 Million | ▼ -48.3% |
| 2017 | 0.19x | NT$45.47 Million | NT$8.44 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow